The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Acadia Pharmaceuticals Inc. | COM | 004225108 | 462,676 | 20,481,442 | SH | SOLE | 20,481,442 | 0 | 0 | ||
Acceleron Pharma Inc. | COM | 00434H108 | 977 | 28,765 | SH | SOLE | 28,765 | 0 | 0 | ||
Achaogen Inc. | COM | 004449104 | 1,396 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Achillion | COM | 00448Q201 | 3,318 | 438,337 | SH | SOLE | 438,337 | 0 | 0 | ||
Acorda Therapeutics, Inc. | COM | 00484M106 | 30,544 | 906,091 | SH | SOLE | 906,091 | 0 | 0 | ||
Aegerion Pharmaceuticals | COM | 00767E102 | 13,283 | 413,922 | SH | SOLE | 413,922 | 0 | 0 | ||
Aerie Pharmaceuticals | COM | 00771V108 | 7,415 | 299,356 | SH | SOLE | 299,356 | 0 | 0 | ||
Agios Pharmaceuticals | COM | 00847X104 | 9,159 | 199,893 | SH | SOLE | 199,893 | 0 | 0 | ||
Alder Biopharmaceuticals, Inc. | COM | 014339105 | 3,078 | 153,350 | SH | SOLE | 153,350 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | COM | 02043Q107 | 733 | 11,600 | SH | SOLE | 11,600 | 0 | 0 | ||
Ambit Biosciences Corp. | COM | 02318X100 | 5,168 | 747,954 | SH | SOLE | 747,954 | 0 | 0 | ||
Amicus Therapeutics | COM | 03152W109 | 1,609 | 481,697 | SH | SOLE | 481,697 | 0 | 0 | ||
Anacor Pharmaceuticals | COM | 032420101 | 57,588 | 3,248,043 | SH | SOLE | 3,248,043 | 0 | 0 | ||
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 11,355 | 1,211,851 | SH | SOLE | 1,211,851 | 0 | 0 | ||
Array Biopharma Inc. | COM | 04269X105 | 6,538 | 1,433,797 | SH | SOLE | 1,433,797 | 0 | 0 | ||
Arrowhead Research Corp. | COM | 042797209 | 20,475 | 1,430,802 | SH | SOLE | 1,430,802 | 0 | 0 | ||
Avanir Pharmaceuticals | COM CLASS A | 05348P401 | 104,670 | 18,558,487 | SH | SOLE | 18,558,487 | 0 | 0 | ||
Biocryst Pharmaceuticals Inc. | COM | 09058V103 | 138,859 | 10,890,872 | SH | SOLE | 10,890,872 | 0 | 0 | ||
BioDelivery Sciences Intl. Inc. | COM | 09060J106 | 5,082 | 421,005 | SH | SOLE | 421,005 | 0 | 0 | ||
Biomarin Pharmaceuticals | COM | 09061G101 | 118,711 | 1,908,230 | SH | SOLE | 1,908,230 | 0 | 0 | ||
Biota Pharmaceuticals | COM | 090694100 | 3,155 | 1,106,910 | SH | SOLE | 1,106,910 | 0 | 0 | ||
Bluebird Bio Inc. | COM | 09609G100 | 7,647 | 198,260 | SH | SOLE | 198,260 | 0 | 0 | ||
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 5,624 | 2,223,053 | SH | SOLE | 2,223,053 | 0 | 0 | ||
Celsus Therapeutics | SPONSORED ADR NE | 15119A202 | 3,706 | 673,887 | SH | SOLE | 673,887 | 0 | 0 | ||
Cerus | COM | 157085101 | 42,523 | 10,246,591 | SH | SOLE | 10,246,591 | 0 | 0 | ||
Chemocentryx Inc. | COM | 16383L106 | 293 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Clovis Oncology | COM | 189464100 | 32,847 | 793,221 | SH | SOLE | 793,221 | 0 | 0 | ||
Concert Pharmaceuticals, Inc. | COM | 206022105 | 4,028 | 398,800 | SH | SOLE | 398,800 | 0 | 0 | ||
Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% | PFD CONV EX 6% | 23254L207 | 108 | 13,253 | SH | SOLE | 13,253 | 0 | 0 | ||
Cytrx Corp. | COM | 232828509 | 5,643 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
Derma Sciences | COM | 249827502 | 40,889 | 3,537,137 | SH | SOLE | 3,537,137 | 0 | 0 | ||
Discovery Laboratories Inc. | COM | 254668403 | 6,501 | 3,652,117 | SH | SOLE | 3,652,117 | 0 | 0 | ||
Dyax Corp. | COM | 26746E103 | 54,540 | 5,681,237 | SH | SOLE | 5,681,237 | 0 | 0 | ||
Enanta Pharmaceuticals | COM | 29251M106 | 3,246 | 75,357 | SH | SOLE | 75,357 | 0 | 0 | ||
Epizyme Inc. | COM | 29428V104 | 6,660 | 214,012 | SH | SOLE | 214,012 | 0 | 0 | ||
Five Prime Therapeutics Inc. | COM | 33830X104 | 308 | 19,823 | SH | SOLE | 19,823 | 0 | 0 | ||
Foundation Medicine Inc. | COM | 350465100 | 2,107 | 78,162 | SH | SOLE | 78,162 | 0 | 0 | ||
Galectin Therapeutics Inc. | COM | 363225202 | 4,143 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
Genomic Health Inc. | COM | 37244C101 | 374,144 | 13,654,902 | SH | SOLE | 13,654,902 | 0 | 0 | ||
Geron Corp. | COM | 374163103 | 1,292 | 402,629 | SH | SOLE | 402,629 | 0 | 0 | ||
Gilead Sciences Inc. | COM | 375558103 | 21,234 | 256,108 | SH | SOLE | 256,108 | 0 | 0 | ||
Halozyme Therapeutics Inc. | COM | 40637H109 | 27,428 | 2,776,143 | SH | SOLE | 2,776,143 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 32,128 | 2,607,784 | SH | SOLE | 2,607,784 | 0 | 0 | ||
Idera Pharmaceuticals Inc. | COM | 45168K306 | 4,678 | 1,613,076 | SH | SOLE | 1,613,076 | 0 | 0 | ||
Ignyta | COM | 451731103 | 5,190 | 571,000 | SH | SOLE | 571,000 | 0 | 0 | ||
Incyte Corp. | COM | 45337C102 | 837,883 | 14,845,559 | SH | SOLE | 14,845,559 | 0 | 0 | ||
Infinity Pharmaceuticals Inc. | COM | 45665G303 | 7,950 | 624,050 | SH | SOLE | 624,050 | 0 | 0 | ||
Insmed Inc. | COM | 457669307 | 6,075 | 304,050 | SH | SOLE | 304,050 | 0 | 0 | ||
Intermune Inc. | COM | 45884X103 | 208,515 | 4,722,869 | SH | SOLE | 4,722,869 | 0 | 0 | ||
Ironwood Pharmaceuticals | COM | 46333X108 | 6,840 | 446,160 | SH | SOLE | 446,160 | 0 | 0 | ||
Isis Pharmaceuticals, Inc. | COM | 464330109 | 3,318 | 96,303 | SH | SOLE | 96,303 | 0 | 0 | ||
Karyopharm Therapeutics | COM | 48576U106 | 4,380 | 94,095 | SH | SOLE | 94,095 | 0 | 0 | ||
Kythera Biopharmaceuticals | COM | 501570105 | 11,943 | 311,255 | SH | SOLE | 311,255 | 0 | 0 | ||
La Jolla Pharmaceuticals, Inc. | COM | 503459604 | 2,035 | 221,631 | SH | SOLE | 221,631 | 0 | 0 | ||
Ligand Pharmaceuticals | COM | 53220K504 | 4,572 | 73,400 | SH | SOLE | 73,400 | 0 | 0 | ||
Lipocine Inc. | COM | 53630X104 | 3,050 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Macrogenics, Inc. | COM | 556099109 | 6,777 | 311,891 | SH | SOLE | 311,891 | 0 | 0 | ||
Mast Therapeutics, Inc. | COM | 057631410 | 1,887 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
Mediwound Ltd. | COM | M68830104 | 2,561 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
Mirati Therapeutics Inc. | COM | 60468T105 | 47,601 | 2,380,074 | SH | SOLE | 2,380,074 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 8,230 | 554,590 | SH | SOLE | 554,590 | 0 | 0 | ||
Novavax Inc. | COM | 670002104 | 5,652 | 1,223,362 | SH | SOLE | 1,223,362 | 0 | 0 | ||
Omeros Corp. | COM | 682143102 | 13,116 | 753,804 | SH | SOLE | 753,804 | 0 | 0 | ||
Ophthotech Corp. | COM | 683745103 | 1,556 | 36,776 | SH | SOLE | 36,776 | 0 | 0 | ||
Orasure Technologies Inc. | SHS | 68554V108 | 2,020 | 234,664 | SH | SOLE | 234,664 | 0 | 0 | ||
Osiris Therapeutics Inc. | COM | 68827R108 | 7,976 | 510,606 | SH | SOLE | 510,606 | 0 | 0 | ||
Pharmacyclics Inc. | COM | 716933106 | 860,458 | 9,591,546 | SH | SOLE | 9,591,546 | 0 | 0 | ||
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 19,179 | 4,449,797 | SH | SOLE | 4,449,797 | 0 | 0 | ||
QLT Inc. | COM | 746927102 | 9,492 | 1,535,863 | SH | SOLE | 1,535,863 | 0 | 0 | ||
Questcor Pharmaceuticals, Inc. | COM | 74835Y101 | 46,245 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Receptos Inc. | COM | 756207106 | 1,018 | 23,900 | SH | SOLE | 23,900 | 0 | 0 | ||
Regado | COM | 75874Q107 | 2,716 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Repros Therapeutics | COM | 76028H209 | 48,071 | 2,778,654 | SH | SOLE | 2,778,654 | 0 | 0 | ||
Rigel Pharmaceuticals | COM | 766559603 | 1,750 | 481,972 | SH | SOLE | 481,972 | 0 | 0 | ||
Salix Pharmaceuticals | COM | 795435106 | 1,063 | 8,621 | SH | SOLE | 8,621 | 0 | 0 | ||
Salix Pharmaceuticals Ltd Put 110 July 14 | COM | 795435956 | 13,063 | 105,900 | SH | SOLE | 105,900 | 0 | 0 | ||
Salix Pharmaceuticals Ltd Put 115 July 14 | COM | 795435956 | 2,368 | 19,200 | SH | SOLE | 19,200 | 0 | 0 | ||
Sangamo Biosceiences, Inc. | COM | 800677106 | 7,983 | 522,764 | SH | SOLE | 522,764 | 0 | 0 | ||
Seattle Genetics, Inc. | COM | 812578102 | 859,562 | 22,472,229 | SH | SOLE | 22,472,229 | 0 | 0 | ||
Stemline Therapeutics Inc. | COM | 85858C107 | 4,968 | 338,671 | SH | SOLE | 338,671 | 0 | 0 | ||
Synageva Biopharma Corp. | COM | 87159A103 | 1,117,213 | 10,660,432 | SH | SOLE | 10,660,432 | 0 | 0 | ||
Synergy Pharmaceuticals | COM | 871639308 | 7,156 | 1,758,271 | SH | SOLE | 1,758,271 | 0 | 0 | ||
Synta Pharmaceuticals | COM | 87162T206 | 2,045 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Tekmire Pharmaceuticals Corp. | COM | 87911B209 | 6,323 | 484,156 | SH | SOLE | 484,156 | 0 | 0 | ||
Tesaro Inc. | COM | 881569107 | 971 | 31,218 | SH | SOLE | 31,218 | 0 | 0 | ||
TG Therapeutics | COM | 88322Q108 | 20,291 | 2,160,965 | SH | SOLE | 2,160,965 | 0 | 0 | ||
Threshold Pharma | COM | 885807206 | 7,232 | 1,826,358 | SH | SOLE | 1,826,358 | 0 | 0 | ||
Ultragenyx Pharmaceuticals | COM | 90400D108 | 4,489 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Uniquere B.V. | COM | N90064101 | 417 | 30,672 | SH | SOLE | 30,672 | 0 | 0 | ||
Vanda Pharmaceuticals, Inc. | COM | 921659108 | 70,741 | 4,372,153 | SH | SOLE | 4,372,153 | 0 | 0 | ||
Versartis Inc. | COM | 92529L102 | 34,935 | 1,245,889 | SH | SOLE | 1,245,889 | 0 | 0 | ||
Xencor | COM | 98401F105 | 6,302 | 542,363 | SH | SOLE | 542,363 | 0 | 0 | ||
Xenoport | COM | 98411C100 | 19,485 | 4,034,112 | SH | SOLE | 4,034,112 | 0 | 0 | ||
Xoma Corp. | COM | 98419J107 | 105,873 | 23,065,972 | SH | SOLE | 23,065,972 | 0 | 0 | ||
Ziopharm Oncology Inc. | COM | 98973P101 | 986 | 244,619 | SH | SOLE | 244,619 | 0 | 0 | ||
Zogenix, Inc. | COM | 98978L105 | 4,724 | 2,350,400 | SH | SOLE | 2,350,400 | 0 | 0 | ||
Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | 70,511 | 22,898,000 | PRN | SOLE | 0 | 0 | 0 | ||
Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | CONV BONDS | 09061GAE1 | 12,895 | 12,500,000 | PRN | SOLE | 0 | 0 | 0 | ||
Gilead 1.625% 5/1/16 | CONV BONDS | 375558AP8 | 78,358 | 21,500,000 | PRN | SOLE | 0 | 0 | 0 | ||
Incyte Corporation Notes 4.75% 10/1/2015 144A | CONV BONDS | 45337CAJ1 | 259,336 | 40,446,000 | PRN | SOLE | 0 | 0 | 0 | ||
Incyte Corporation Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | 345,981 | 259,000,000 | PRN | SOLE | 0 | 0 | 0 | ||
Incyte Corporation Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | 371,605 | 274,500,000 | PRN | SOLE | 0 | 0 | 0 | ||
Intermune Inc Notes 5% 3/1/15 | CONV BONDS | 45884XAD5 | 39,842 | 16,860,000 | PRN | SOLE | 0 | 0 | 0 | ||
Intermune Inc Notes 2.5% 12/15/17 | CONV BONDS | 45884XAF0 | 141,190 | 41,000,000 | PRN | SOLE | 0 | 0 | 0 | ||
Medivation 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | 55,324 | 34,720,000 | PRN | SOLE | 0 | 0 | 0 | ||
Salix 2.75% 5/15/15 | CONV BONDS | 795435AC0 | 585,836 | 219,440,000 | PRN | SOLE | 0 | 0 | 0 | ||
Salix 1.5% 3/15/19 | CONV BONDS | 795435AE6 | 29,447 | 15,000,000 | PRN | SOLE | 0 | 0 | 0 |